Effects of PIR and PFS on Pain, ROM, and Disabilty in Tight Hamstring Syndrome
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Jan 22, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how two different stretching techniques—post-isometric relaxation (PIR) and post-facilitation stretch (PFS)—affect pain, flexibility, and disability in people with tight hamstring syndrome. If you are between 18 and 35 years old and have tight hamstring muscles, you might be eligible to participate. To qualify, you should have difficulty fully extending your knee and should not have any serious medical issues, such as back pain that travels down your leg, past injuries to your hip, or any neurological conditions.
Participants in the trial will receive hot pack therapy and core strengthening exercises for four weeks. One group will try the PIR technique, while the other group will practice PFS. Researchers will measure changes in pain levels, flexibility, and disability at the start and end of the trial to see which method works better. This study aims to find effective ways to help individuals with tight hamstrings feel better and improve their movement.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Both male and female
- • Age between 18 to 35 years(45)
- • Bilateral hamstring muscle tightness
- • Individuals having lack of Active knee extension more than 20 degrees(46)
- Exclusion Criteria:
- • Low back pain radiating to the back of thigh
- • History of fracture, dislocation of hip(47)
- • Acute or chronic hamstring injury
- • Any neurological disease(48)
- • Congenital deformity of the lower limb
- • Inflammatory condition that affects motion
- • A history of a cervical whiplash injury(45)
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lahore, Punjab, Pakistan
Patients applied
Trial Officials
Hira Shaukat, TDPT
Principal Investigator
Riphah International University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported